Copayment level and medication adherence in type 2 diabetes patients managed with insulin aspart pen therapy

被引：1
|
作者：
Lee, W. C.
Balu, S.
Cobden, D.
Joshi, A., V
Pashos, C. L.
机构：
[1] Abt Associates Inc, Bethesda, MD USA
[2] Abt Associates Inc, Lexington, MA USA
[3] Novo Nordisk Inc, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68730-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A63 / A63
页数：1
相关论文
共 50 条
  • [1] Impact of initiating or converting to treatment with an insulin aspart analog pen on medication adherence in type 2 diabetes patients on vial/syringe insulin
    Balu, S.
    Lee, W. C.
    Cobden, D.
    Joshi, A., V
    Pashos, C. L.
    VALUE IN HEALTH, 2007, 10 (03) : A68 - A68
  • [2] Pen devices to improve patient adherence with insulin therapy in type 2 diabetes
    Goldstein, Henry Howard
    POSTGRADUATE MEDICINE, 2008, 120 (03) : 172 - 179
  • [3] Insulin aspart in patients with type 2 diabetes
    Fernandez-Garcia, Diego
    Sebastian-Ochoa, Arantzazu
    AVANCES EN DIABETOLOGIA, 2012, 28 : 27 - 31
  • [4] A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir in a Pen Device or NPH Insulin in a Vial
    Buysman, Erin K.
    Conner, Christopher
    Liu, Fang
    Aagren, Mark
    Bouchard, Jonathan
    DIABETES, 2011, 60 : A628 - A628
  • [5] Adherence to Insulin Pen Therapy Is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus
    Chandran, Arthi
    Bonafede, Machaon K.
    Nigam, Sonali
    Saltiel-Berzin, Rita
    Hirsch, Laurence J.
    Lahue, Betsy J.
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (03): : 148 - 157
  • [6] Insulinglulisine and aspart insulin are equipotent in intensified insulin therapy of patients with type 2 diabetes mellitus
    Jungmann, E.
    Bolle, J.
    Schmitz, C.
    Snelting, U.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 : 67 - 68
  • [7] Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
    Lee, Won Chan
    Balu, Sanjeev
    Cobden, David
    Joshi, Ashish V.
    Pashos, Chris L.
    CLINICAL THERAPEUTICS, 2006, 28 (10) : 1712 - 1725
  • [8] Medication Adherence in Patients With Type 2 Diabetes
    Hennessey, Erin K.
    Peters, Golden L.
    US PHARMACIST, 2019, 44 (06) : 40 - 46
  • [9] Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: A retrospective database analysis
    Pawaskar, Manjiri D.
    Camacho, Fabian T.
    Anderson, Roger T.
    Cobden, David
    Joshi, Ashish V.
    Balkrishnan, Rajesh
    CLINICAL THERAPEUTICS, 2007, 29 : 1294 - 1305
  • [10] Insulin therapy among type 2 diabetes patients: Impact of conversion to a pen device on adherence, hypoglycemic events, and costs
    Lee, W. C.
    Balu, S.
    Cobden, D.
    Joshi, A., V
    Pashos, C. L.
    VALUE IN HEALTH, 2006, 9 (06) : A187 - A187
12345